|
|
Cloning and Expression of PLCE1 Gene and Its Haplotypes of rs2274223 and rs3765524 |
LI Da, DAI Peng, WANG Wei, ZHANG Wen-tao, WANG Qin, SHU Yi, ZHU Chun-lai, JI Qi-feng, LIANG Ping, YAN Zhen |
Department of Pharmacogenomics, School of Pharmacy, Fourth Military Medical University, Xi'an 710032, China |
|
|
Abstract Objective: The aimed is to address the question of how PLCE1 gene polymorphism or genotypes affect its expression by cloning human PLCE1 gene and constructing eukaryotic expression vector of PLCE1 rs2274223G-rs3765524T(PLCE1 Minor) and PLCE1 rs2274223A-rs3765524C(PLCE1 Major). Methods: Overlap extension PCR (SOE-PCR) and In-Fusion Technology were adopted to construct PLCE1 eukaryotic expression vector. The targeted gene was acquired by double point mutations based on homologous recombination. The expression of overexpressed PLCE1 by gene transfection was observed by real-time quantitative PCR and Western blotting. Results: The full-length human PLCE1 that contains 6 927 base pairs was acquired and confirmed by DNA sequencing. By comparing with the reference sequence (NM_016341) in NCBI database, it was found to exactly matched the reference sequence except a 18bp insertion in the region of 3 554~3 572bp. Additionally, the recombinant plasmids of two PLCE1 haplotypes, PLCE1 Minor and PLCE1 Major, were constructed respectively. By transfection, it was found that the expression levels of mRNA and protein of PLCE1 Minor were significantly higher than that of PLCE1 Major. Conclusion: A new PLCE1 transcript variant was discovered and the eukaryotic expression vectors of two haplotypes of human PLCE1 were successfully constructed. It was found that PLCE1 rs2274223G-rs3765524T promotes its mRNA and protein expression. These findings laid the foundation of revealing the correlation between PLCE1 single nucleotide polymorphisms (SNP) and cancer susceptibility.
|
Received: 18 September 2016
Published: 25 December 2016
|
|
|
Cite this article:
LI Da, DAI Peng, WANG Wei, ZHANG Wen-tao, WANG Qin, SHU Yi, ZHU Chun-lai, JI Qi-feng, LIANG Ping, YAN Zhen. Cloning and Expression of PLCE1 Gene and Its Haplotypes of rs2274223 and rs3765524. China Biotechnology, 2016, 36(12): 1-7.
URL:
https://manu60.magtech.com.cn/biotech/DOI:10.13523/j.cb.20161201 OR https://manu60.magtech.com.cn/biotech/Y2016/V36/I12/1
|
|
|
[1] |
Sorli S C, Bunney T D, Sugden P H, et al. Signaling properties and expression in normal and tumor tissues of two phospholipase C epsilon splice variants. Oncogene,2005,24(1):90-100.
|
|
|
[2] |
Martins M, Mccarthy A, Baxendale R, et al. Tumor suppressor role of phospholipase C epsilon in Ras-triggered cancers. Proc Natl Acad Sci U S A,2014,111(11):4239-4244.
|
|
|
[3] |
Cui X B, Li S, Li T T, et al. Targeting oncogenic PLCE1 by miR-145 impairs tumor proliferation and metastasis of esophageal squamous cell carcinoma. Oncotarget,2016,7(2):1777-1795.
|
|
|
[4] |
Han N, Zhao W, Zhang Z, et al. MiR-328 suppresses the survival of esophageal cancer cells by targeting PLCE1. Biochem Biophys Res Commun,2016,470(1):175-180.
|
|
|
[5] |
Cui X B, Pang X L, Li S, et al. Elevated expression patterns and tight correlation of the PLCE1 and NF-kappaB signaling in Kazakh patients with esophageal carcinoma. Med Oncol,2014,31(1):791.
|
|
|
[6] |
Wang L D, Zhou F Y, Li X M, et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet,2010,42(9):759-763.
|
|
|
[7] |
Abnet C C, Freedman N D, Hu N, et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet,2010,42(9):764-767.
|
|
|
[8] |
Dusaban S S, Brown J H. PLCepsilon mediated sustained signaling pathways. Adv Biol Regul,2015,57:17-23.
|
|
|
[9] |
Qu Y, Zhang S, Cui L, et al. Two novel polymorphisms in PLCE1 are associated with the susceptibility to esophageal squamous cell carcinoma in Chinese population. Dis Esophagus,2016.
|
|
|
[10] |
Guo L Y, Zhang S, Suo Z, et al. PLCE1 Gene in esophageal cancer and interaction with environmental factors. Asian Pac J Cancer Prev,2015,16(7):2745-2749.
|
|
|
[11] |
Yuan J, Li Y, Tian T, et al. Risk prediction for early-onset gastric carcinoma:a case-control study of polygenic gastric cancer in Han Chinese with hereditary background. Oncotarget,2016,7(23):33608-33615.
|
|
|
[12] |
Mou X, Li T, Wang J, et al. Genetic variation of BCL2(rs2279115), NEIL2(rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1(rs3765524, rs10509670) genes and their correlation to gastric cancer risk based on universal tagged arrays and Fe3O4 magnetic nanoparticles. J Biomed Nanotechnol,2015,11(11):2057-2066.
|
|
|
[13] |
Sun H, Wu X, Wu F, et al. Associations of genetic variants in the PSCA, MUC1 and PLCE1 genes with stomach cancer susceptibility in a Chinese population. PLoS One,2015,10(2):e117576.
|
|
|
[14] |
Mocellin S, Verdi D, Pooley K A, et al. Genetic variation and gastric cancer risk:a field synopsis and meta-analysis. Gut,2015,64(8):1209-1219.
|
|
|
[15] |
Malik M A, Umar M, Gupta U, et al. Phospholipase C epsilon 1(PLCE1 rs2274223A>G, rs3765524C>T and rs7922612C>T) polymorphisms and esophageal cancer risk in the Kashmir Valley. Asian Pac J Cancer Prev,2014,15(10):4319-4323.
|
|
|
[16] |
Luo D, Gao Y, Wang S, et al. Genetic variation in PLCE1 is associated with gastric cancer survival in a Chinese population. J Gastroenterol,2011,46(11):1260-1266.
|
|
|
[17] |
Wang L D, Bi X, Song X, et al. A sequence variant in the phospholipase C epsilon C2 domain is associated with esophageal carcinoma and esophagitis. Mol Carcinog,2013,52 Suppl 1:e80-e86.
|
|
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|